Screener
Edgewise Therapeutics, Inc. EWTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
| Assets | As of / March 31, 2026 / (unaudited) | As of / December 31, 2025 |
|---|---|---|
| Prepaid expenses and other assets | 10,230 | 13,276 |
| Total current assets | 509,792 | 543,385 |
| Property and equipment, net | 7,396 | 7,831 |
| Operating lease right-of-use asset | 1,334 | 1,387 |
| Total assets | $518,522 | $552,603 |
| Liabilities and stockholders' equity | ||
| Current liabilities | ||
| Accounts payable | $7,293 | $6,006 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edgewise Therapeutics, Inc.'s operating lease ROU assets?
- Edgewise Therapeutics, Inc. (EWTX) reported operating lease ROU assets of $1.33M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Edgewise Therapeutics, Inc.'s operating lease ROU assets decreased by 12.7% year-over-year, from $1.53M to $1.33M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s operating lease ROU assets?
- Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s operating lease ROU assets has grown at a 1.7% compound annual growth rate (CAGR), from $1.32M to $1.39M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Edgewise Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude